Interdisciplinary research: Noradrenergic regulation of adaptive immunity

To understand the complexity of mechanisms involved in the regulation of adaptive immunity by the sympathetic neurotransmitter norepinephrine and adrenergic receptor stimulation, there must be a rich history of basic science and clinical findings upon which to form hypotheses for testing, as well as a rich supply of individuals trained in two or more disciplines. This review is intended to offer a tour of the past, present, and future discoveries that have been made in the area of adrenergic regulation of adaptive immunity, as well as share a vision of how our field of study will progress years from now, given that every individual who contributes to the interdisciplinary nature of our research is valued. And finally, this review will discuss how the lessons from the past can help us to attain a vision of interdisciplinary research for the future.

[1]  Kathryn J. Jones,et al.  Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury , 2005, Brain, Behavior, and Immunity.

[2]  D. Kasprowicz,et al.  Stimulation of the B Cell Receptor, CD86 (B7-2), and the β2-Adrenergic Receptor Intrinsically Modulates the Level of IgG1 and IgE Produced per B Cell1 , 2000, The Journal of Immunology.

[3]  D. Felten,et al.  Sympathetic innervation of murine thymus and spleen: A comparative histofluorescence study , 1981, The Anatomical record.

[4]  V. Sanders,et al.  Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice , 2000, Journal of neuroscience research.

[5]  V. Sanders,et al.  Activation of Antigen-Specific CD4+ Th2 Cells and B Cells In Vivo Increases Norepinephrine Release in the Spleen and Bone Marrow1 , 2000, The Journal of Immunology.

[6]  Kathryn J. Jones,et al.  CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection , 2003, Brain, Behavior, and Immunity.

[7]  V. Sanders,et al.  IFN-γ Production by Th1 Cells Generated from Naive CD4+ T Cells Exposed to Norepinephrine1 , 2001, The Journal of Immunology.

[8]  V. Sanders,et al.  B Cell Receptor- and β2-Adrenergic Receptor-Induced Regulation of B7-2 (CD86) Expression in B Cells1 , 2002, The Journal of Immunology.

[9]  H. Besedovsky,et al.  Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.

[10]  J. Uhr,et al.  Characterization of the physical interaction between antigen-specific B and T cells. , 1986, Journal of immunology.

[11]  Kathryn J. Jones,et al.  CD4-Positive T Cell-Mediated Neuroprotection Requires Dual Compartment Antigen Presentation , 2004, The Journal of Neuroscience.

[12]  V. Sanders,et al.  Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. , 1999, Journal of immunology.

[13]  Kathryn J. Jones,et al.  Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice , 2002, Brain, Behavior, and Immunity.

[14]  David L. Felten,et al.  Sympathetic innervation of murine thymus and spleen: Evidence for a functional link between the nervous and immune systems , 1981, Brain Research Bulletin.

[15]  A. Munson,et al.  Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. , 1984, The Journal of pharmacology and experimental therapeutics.

[16]  Nicholas W. Kin,et al.  CD86 and β2-Adrenergic Receptor Signaling Pathways, Respectively, Increase Oct-2 and OCA-B Expression and Binding to the 3′-IgH Enhancer in B Cells* , 2004, Journal of Biological Chemistry.

[17]  E. Sorkin,et al.  The immune response evokes changes in brain noradrenergic neurons. , 1983, Science.

[18]  A. Munson,et al.  Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro. , 1984, The Journal of pharmacology and experimental therapeutics.

[19]  Behaviorally Conditioned Immunosuppression , 1974 .

[20]  V. Sanders,et al.  Exacerbation of Facial Motoneuron Loss after Facial Nerve Transection in Severe Combined Immunodeficient (scid) Mice , 1999, The Journal of Neuroscience.

[21]  J. Fenters,et al.  Development of a testing battery to assess chemical-induced immunotoxicity: National toxicology program's guidelines for immunotoxicity evaluation in mice , 1988 .

[22]  V. Sanders,et al.  Selective Regulation of Mature IgG1 Transcription by CD86 and β2-Adrenergic Receptor Stimulation1 , 2003, The Journal of Immunology.

[23]  G. Solomon,et al.  EMOTIONS, IMMUNITY, AND DISEASE; A SPECULATIVE THEORETICAL INTEGRATION. , 1964, Archives of general psychiatry.

[24]  V. Sanders,et al.  CD86 and beta2-adrenergic receptor stimulation regulate B-cell activity cooperatively. , 2005, Trends in immunology.

[25]  E. Sorkin,et al.  Immunoregulation mediated by the sympathetic nervous system, II. , 1979, Cellular immunology.

[26]  Ciriana Orabona,et al.  CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 , 2004, Nature Immunology.

[27]  J. Uhr,et al.  Clonal analysis of B cells induced to secrete IgG by T cell-derived lymphokine(s) , 1984, The Journal of experimental medicine.

[28]  H. Haas,et al.  Hypothalamic changes during the immune response. , 1977, European journal of immunology.

[29]  V. Sanders,et al.  Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. , 1997, Journal of immunology.

[30]  A. Munson,et al.  Norepinephrine and the antibody response. , 1985, Pharmacological reviews.

[31]  D. Kasprowicz,et al.  Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. , 1997, Journal of immunology.

[32]  R. Straub,et al.  Norepinephrine, the β-Adrenergic Receptor, and Immunity , 2002, Brain, Behavior, and Immunity.